z-logo
Premium
Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis
Author(s) -
Straub Shana F,
Drage Michael G,
Gonzalez Raul S
Publication year - 2018
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.13485
Subject(s) - medicine , familial adenomatous polyposis , gastroenterology , dysplasia , gastric polyp , cancer , adenomatous polyposis coli , colorectal cancer , stomach
Aims Dysplastic fundic gland polyps (d‐ FGP s) typically arise in patients with familial adenomatous polyposis ( FAP ) but may occur in non‐syndromic patients. They rarely become malignant, but their significance is unclear, especially in non‐syndromic patients. We aimed to compare d‐ FGP s in patients with and without FAP , using clinicopathologic findings and β‐catenin immunohistochemistry ( IHC ). Methods and results We identified 124 fundic gland polyps with low‐grade dysplasia ( LGD ) or high‐grade dysplasia ( HGD ) or indefinite for dysplasia ( IFD ) from 66 patients (27 with FAP ; 39 non‐syndromic). We recorded patient sex, age at first d‐ FGP , time until subsequent d‐ FGP (if any), history of non‐gastric cancer (no patients had gastric cancer), proton‐pump inhibitor use, and the presence of Helicobacter pylori . β‐Catenin IHC was performed on cases with available blocks. The mean age at d‐ FGP diagnosis was 31 years for FAP patients and 61 years for non‐syndromic patients ( P < 0.0001). Sixteen FAP patients (59%) developed at least one subsequent d‐ FGP , as compared with 10 (27%) non‐syndromic patients ( P = 0.0099). The median time between d‐ FGP detection was 11.5 months in FAP patients and 7 months in non‐syndromic patients ( P = 0.82). Six FAP patients (22%) and 17 non‐syndromic patients (44%) had non‐gastric malignancies ( P = 0.11). β‐Catenin IHC showed nuclear positivity in 14 of 112 (13%) d‐ FGP s: 12 of 94 with LGD , two of three with HGD , and none of 15 with IFD polyps. Conclusions Familial adenomatous polyposis patients develop d‐ FGP s earlier and more often develop additional ones than non‐syndromic patients. d‐ FGP s in FAP and non‐syndromic patients have similar low rates of β‐catenin nuclear IHC positivity. FAP and non‐syndromic patients developed non‐gastric cancers at similar rates, suggesting that d‐ FGP s may portend a general increased risk of carcinogenesis in non‐syndromic patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom